Sort
21,281 grants matching “influenza”
Project 2
$919,757Maria Virginia Pascual · St. Jude Children'S Research Hospital · U19 · FY2025 · AI
Development of novel immunotherapy for influenza virus infection
$919,127Kazue Takahashi · Massachusetts General Hospital · U01 · FY2009 · AI
Dissecting Polyclonal Sera to Reveal Correlates of Productive Immune Responses to HIV
$919,034Andrew Barrett Ward · Scripps Research Institute, The · R01 · FY2018 · AI
T Cell Immune Responses To HIV And Other Pathogens
$918,847Daniel Cesar Douek · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Mechanisms of Immune Interference Between Respiratory Allergic Inflammation and Antiviral Immunity
$917,532Andre Ballesteros-Tato · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Dissecting Polyclonal Sera to Reveal Correlates of Productive Immune Responses to HIV
$917,515Andrew Barrett Ward · Scripps Research Institute, The · R01 · FY2022 · AI
Establishing Early Brain Signatures associated with Maternal Immune Activation Exposure
$917,129Marisa N Spann · Columbia University Health Sciences · R01 · FY2025 · MH
Influenza and Emerging Infectious Diseases
$917,122Richard Davey · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Studies of IGHV Germline Gene Polymorphism, Utilization & Shifting for Seasonal Influenza Vaccine Induced Broadly Neutralizing Antibody Responses
$917,070Wayne A. Marasco · Dana-Farber Cancer Inst · R01 · FY2019 · AI
The generation and protective function of lung tissue resident memory T cells following SARS-CoV-2 infection or vaccination
$916,382John Ross Teijaro · Scripps Research Institute, The · R01 · FY2022 · AI
Dissecting Polyclonal Sera to Reveal Correlates of Productive Immune Responses to HIV
$916,133Andrew Barrett Ward · Scripps Research Institute, The · R01 · FY2021 · AI
Immunosenescence Studies of Acute Radiation Exposure in Atomic Bomb Survivors
$915,436Kei Nakachi · Radiation Effects Researc · N01 · FY2014 · AI
The Building Resistance Against Viral Entities (BRAVE) Innovation Center
$914,937Peter Joseph Halfmann · University Of Wisconsin-Madison · U18 · FY2024 · FD
The Building Resistance Against Viral Entities (BRAVE) Innovation Center
$914,937Peter Joseph Halfmann · University Of Wisconsin-Madison · U18 · FY2025 · FD
Enhanced Surveillance-Newly Vaccine Preventable Diseases
$914,792Peter G Szilagyi · University Of Rochester · U01 · FY2008 · IP
Enhanced Surveillance: New Vaccine Preventable Diseases
$914,792Kathryn Margaret Edwards · Vanderbilt University · U01 · FY2008 · IP
Antigen Presentation to Self-reactive T Cells in Human Autoimmune Diseases
$914,628Kai W Wucherpfennig · Dana-Farber Cancer Inst · P01 · FY2008 · AI
Tissue factor-dependent coagulation in thrombosis and immune responses
$914,340Nigel Mackman · Univ Of North Carolina Chapel Hill · R35 · FY2024 · HL
A Novel Th17-inducing Mucosal Vaccine for Tuberculosis
$914,044Shabaana A. Khader · University Of Chicago · R01 · FY2023 · AI
Novel mechanisms regulating immunity to respiratory virus infection
$913,500Silke Paust · Jackson Laboratory · R01 · FY2023 · AI
Comparison of High Dose vs. Standard Dose Influenza Vaccines in Lung Allograft Recipients
$913,378Natasha Bassam Halasa · Vanderbilt University Medical Center · U01 · FY2022 · AI
Development of a Broad-Spectrum Inhibitor against Seasonal and Highly-Pathogenic Influenza Viruses
$913,220Richard K. Plemper · Georgia State University · R01 · FY2023 · AI
Discrimination of nonself by innate immune receptors
$912,922Joseph Marcotrigiano · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Skin vaccination and generation of protective lung-tropic memory T cells
$912,384Thomas S. Kupper · Brigham And Women'S Hospital · R01 · FY2025 · AI
Immune Responses To HIV And Other Pathogens
$912,355Daniel Cesar Douek · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI